Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Higgins, D. Jelovac, E. Barnathan, B. Blair, S. Slater, P. Powers, J. Zorzi, S. Jeter, G. Oliver, J. Fetting, L. Emens, Carol Riley, V. Stearns, F. Diehl, P. Angenendt, Peng Huang, L. Cope, P. Argani, K. Murphy, K. Bachman, J. Greshock, A. Wolff, B. Park (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral BloodClinical Cancer Research, 18
T. Fehm, O. Hoffmann, B. Aktas, S. Becker, E. Solomayer, D. Wallwiener, R. Kimmig, S. Kasimir-Bauer (2009)
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsBreast Cancer Research : BCR, 11
A Bardia, P Huang, Z Zhang, L Sokoll, JN Ingle, LA Carey (2010)
Circulating tumor cells (CTCs) and CA27.29 as predictors of outcome in metastatic breast cancer (MBC) patients in the prospective TBCRC 005 Biomarker studyJ Clin Oncol, 28
N. Tiwari, A. Gheldof, M. Tatari, G. Christofori (2012)
EMT as the ultimate survival mechanism of cancer cells.Seminars in cancer biology, 22 3
Daniel Hayes, T. Walker, Baljit Singh, E. Vitetta, J. Uhr, S. Gross, C. Rao, G. Doyle, L. Terstappen (2002)
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer.International journal of oncology, 21 5
C. Paoletti (2013)
Abstract OT1-3-01: Characterization of circulating tumor cells from subjects with metastatic breast cancer using the CTC-endocrine therapy index: The COMETI-P2-2012.0 trialCancer Research, 73
A. Lucci, C. Hall, A. Lodhi, A. Bhattacharyya, A. Anderson, Lianchun Xiao, I. Bedrosian, H. Kuerer, S. Krishnamurthy (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study.The Lancet. Oncology, 13 7
J. Aerts, W. Wynendaele, Robert Paridaens, Christiaens Mr, W. Bogaert, A. Oosterom, F. Vandekerckhove (1999)
A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood.Annals of oncology : official journal of the European Society for Medical Oncology, 12 1
F. Coumans, S. Siesling, L. Terstappen (2013)
Detection of cancer before distant metastasisBMC Cancer, 13
M. Wallwiener, A. Hartkopf, I. Baccelli, S. Riethdorf, S. Schott, K. Pantel, F. Marmé, C. Sohn, A. Trumpp, B. Rack, B. Aktas, E. Solomayer, V. Müller, W. Janni, A. Schneeweiss, T. Fehm (2012)
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancerBreast Cancer Research and Treatment, 137
Lixin Zhang, Lon Ridgway, M. Wetzel, Jason Ngo, Wei Yin, Disha Kumar, Jerry Goodman, Morris Groves, Dario Marchetti (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain MetastasisScience Translational Medicine, 5
A. Bardia, Peng Huang, Zhen Zhang, L. Sokoll, J. Ingle, L. Carey, N. Lin, R. Nanda, K. Visvanathan, A. Wolff (2010)
Circulating tumor cell (CTC) and CA2729 as predictors of outcome in patients with metastatic breast cancer (MBC) in the prospective TBCRC 005 biomarker study.Journal of Clinical Oncology, 28
S. Dawson, D. Tsui, M. Murtaza, Heather Biggs, O. Rueda, S. Chin, M. Dunning, D. Gale, T. Forshew, B. Mahler-Araujo, S. Rajan, S. Humphray, J. Becq, D. Halsall, M. Wallis, D. Bentley, C. Caldas, N. Rosenfeld (2013)
Analysis of circulating tumor DNA to monitor metastatic breast cancer.The New England journal of medicine, 368 13
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. Somerfield, D. Hayes, R. Bast (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.Journal of oncology practice, 3 6
L Harris, H Fritsche, R Mennel (2007)
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerJ Clin Oncol., 25
Minetta Liu, P. Shields, R. Warren, P. Cohen, M. Wilkinson, Y. Ottaviano, Suman Rao, J. Eng-Wong, F. Seillier-Moiseiwitsch, A. Noone, C. Isaacs (2009)
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 31
U. Giorgi, Vicente Valero, E. Rohren, M. Mego, G. Doyle, Michelle Miller, N. Ueno, B. Handy, J. Reuben, H. Macapinlac, G. Hortobagyi, Massimo Cristofanilli (2010)
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 21 1
G. Vona, G. Vona, A. Sabile, Malek Louha, V. Sitruk, S. Romana, K. Schütze, Frédérique Capron, D. Franco, M. Pazzagli, M. Vekemans, B. Lacour, C. Bréchot, P. Paterlini-Bréchot, P. Paterlini-Bréchot (2000)
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells.The American journal of pathology, 156 1
V. Georgoulias, V. Bozionelou, S. Agelaki, M. Perraki, S. Apostolaki, G. Kallergi, K. Kalbakis, A. Xyrafas, D. Mavroudis (2012)
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.Annals of oncology : official journal of the European Society for Medical Oncology, 23 7
J. Pierga, J. Pierga, D. Hajage, T. Bachelot, S. Delaloge, E. Brain, M. Campone, V. Diéras, E. Rolland, L. Mignot, C. Mathiot, F. Bidard, F. Bidard (2012)
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.Annals of oncology : official journal of the European Society for Medical Oncology, 23 3
T. Nakagawa, S. Martinez, Y. Goto, K. Koyanagi, M. Kitago, T. Shingai, D. Elashoff, X. Ye, F. Singer, A. Giuliano, D. Hoon (2007)
Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph NodesClinical Cancer Research, 13
R. Ghossein, S. Bhattacharya, J. Rosai (1999)
Molecular detection of micrometastases and circulating tumor cells in solid tumors.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 8
E. Ozkumur, Ajay Shah, Jordan Ciciliano, B. Emmink, D. Miyamoto, E. Brachtel, Min Yu, Pin-i Chen, B. Morgan, Julie Trautwein, Anya Kimura, S. Sengupta, Shannon Stott, N. Karabacak, T. Barber, John Walsh, Kyle Smith, P. Spuhler, J. Sullivan, Richard Lee, D. Ting, Xi Luo, A. Shaw, A. Bardia, L. Sequist, D. Louis, S. Maheswaran, R. Kapur, D. Haber, M. Toner (2013)
Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor CellsScience Translational Medicine, 5
L. Hoefnagel, M. Vijver, H. Slooten, P. Wesseling, J. Wesseling, P. Westenend, J. Bart, C. Seldenrijk, I. Nagtegaal, J. Oudejans, P. Valk, P. Groep, E. Vries, E. Wall, P. Diest (2010)
Receptor conversion in distant breast cancer metastasesBreast Cancer Research : BCR, 12
C. Osborne, J. Pippen, S. Jones, Leroy Parker, M. Ellis, S. Come, Stan Gertler, J. May, Gary Burton, I. Dimery, A. Webster, C. Morris, R. Elledge, Aman Buzdar (2002)
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 16
M. Cristofanilli, G. Budd, M. Ellis, A. Stopeck, J. Matera, M. Miller, J. Reuben, G. Doyle, W. Allard, L. Terstappen, D. Hayes (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.The New England journal of medicine, 351 8
M. Wetzel, Jason Ngo, W. Yin, Disha Kumar, J. Goodman, D. Marchetti (2013)
A Correction to the Research Article Titled: "The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis" by L. Zhang, L. D. Ridgway,
H. Hou, M. Warkiani, B. Khoo, Zirui Li, R. Soo, D. Tan, W. Lim, Jongyoon Han, A. Bhagat, C. Lim (2013)
Isolation and retrieval of circulating tumor cells using centrifugal forcesScientific Reports, 3
G. Somlo, S. Lau, P. Frankel, H. Hsieh, Xiaohe Liu, Lixin Yang, R. Krivacic, R. Bruce (2011)
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technologyBreast Cancer Research and Treatment, 128
E. Racila, D. Euhus, A. Weiss, C. Rao, J. Mcconnell, L. Terstappen, J. Uhr (1998)
Detection and characterization of carcinoma cells in the blood.Proceedings of the National Academy of Sciences of the United States of America, 95 8
J. Smerage, W. Barlow, D. Hayes, E. Winer, B. Leyland-Jones, G. Srkalović, S. Tejwani, A. Schott, M. O'Rourke, D. Lew, J. Gralow, R. Livingston, G. Hortobagyi (2013)
Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessmentCancer Research, 73
J. Fischer, D. Niederacher, S. Topp, E. Honisch, S. Schumacher, N. Schmitz, Luisa Föhrding, C. Vay, I. Hoffmann, N. Kasprowicz, P. Hepp, S. Mohrmann, U. Nitz, Antje Stresemann, T. Krahn, Tanja Henze, Evelyn Griebsch, K. Raba, J. Rox, F. Wenzel, C. Sproll, W. Janni, T. Fehm, C. Klein, W. Knoefel, N. Stoecklein (2013)
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patientsProceedings of the National Academy of Sciences, 110
J. Gallant, Elizabeth Matthew, Hairong Cheng, R. Harouaka, Nicholas Lamparella, Miriam Kunkel, Zhaohai Yang, Harold Harvey, Leah Cream, Suresh Kumar, Gavin Robertson, Siyang Zheng, J. Drabick, C. Truica, W. El-Deiry (2013)
Predicting therapy response in live tumor cells isolated with the flexible micro spring array deviceCell Cycle, 12
L. Lindström, E. Karlsson, U. Wilking, U. Johansson, J. Hartman, E. Lidbrink, T. Hatschek, L. Skoog, J. Bergh (2012)
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 21
R. Krivacic, A. Ladányi, D. Curry, H. Hsieh, P. Kuhn, D. Bergsrud, Jane Kepros, T. Barbera, M. Ho, L. Chen, R. Lerner, R. Bruce (2004)
A rare-cell detector for cancer.Proceedings of the National Academy of Sciences of the United States of America, 101 29
Min Yu, A. Bardia, Ben Wittner, Shannon Stott, Malgorzata Smas, D. Ting, S. Isakoff, Jordan Ciciliano, Marissa Wells, Ajay Shah, K. Concannon, M. Donaldson, L. Sequist, E. Brachtel, D. Sgroi, J. Baselga, Sridhar Ramaswamy, M. Toner, D. Haber, S. Maheswaran (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal CompositionScience, 339
Y. Ko, Michael Klinz, G. Totzke, I. Gouni-Berthold, A. Sachinidis, Hans-Jürgen Vetter (1998)
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.Clinical cancer research : an official journal of the American Association for Cancer Research, 4 9
M. Tewes, B. Aktas, A. Welt, S. Mueller, S. Hauch, R. Kimmig, S. Kasimir-Bauer (2009)
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 115
G. Budd, M. Cristofanilli, M. Ellis, A. Stopeck, E. Borden, M. Miller, J. Matera, M. Repollet, G. Doyle, L. Terstappen, D. Hayes (2006)
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast CancerClinical Cancer Research, 12
D. Hayes, M. Cristofanilli, G. Budd, M. Ellis, A. Stopeck, M. Miller, J. Matera, W. Allard, G. Doyle, L. Terstappen (2006)
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 12
B. Aktas, V. Müller, M. Tewes, Julia Zeitz, S. Kasimir-Bauer, C. Loehberg, B. Rack, A. Schneeweiss, T. Fehm (2011)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.Gynecologic oncology, 122 2
D. Peeters, B. Laere, G. Eynden, S. Laere, Françoise Rothé, M. Ignatiadis, A. Sieuwerts, Diether Lambrechts, A. Rutten, P. Dam, Patrick Pauwels, Marc Peeters, Peter Vermeulen, L. Dirix (2013)
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sortingBritish Journal of Cancer, 108
L. Flores, L. Flores, D. Kindelberger, D. Kindelberger, A. Ligon, A. Ligon, M. Capelletti, M. Fiorentino, M. Loda, M. Loda, E. Cibas, E. Cibas, P. Jänne, I. Krop (2010)
Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancerBritish Journal of Cancer, 102
P. Wülfing, J. Borchard, H. Buerger, S. Heidl, K. Zänker, L. Kiesel, B. Brandt (2006)
HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer PatientsClinical Cancer Research, 12
A. Sieuwerts, B. Mostert, J. Vries, D. Peeters, F. Jongh, J. Stouthard, L. Dirix, P. Dam, Anne Galen, Vanja Weerd, J. Kraan, P. Spoel, Raquel Ramírez-Moreno, C. Deurzen, M. Smid, Jack Yu, John Jiang, Yixin Wang, J. Gratama, S. Sleijfer, J. Foekens, J. Martens (2011)
mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer PatientsClinical Cancer Research, 17
Jang-Fang Kuo, Wea‐Long Lin, Chih‐Ping Han (2011)
Detection of minimal residual disease in blood and bone marrow in early stage breast cancerCancer, 117
S. Kasimir-Bauer, O. Hoffmann, D. Wallwiener, R. Kimmig, T. Fehm (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsBreast Cancer Research : BCR, 14
Antonio Giordano, Antonio Giordano, M. Giuliano, M. Giuliano, M. Laurentiis, G. Arpino, S. Jackson, B. Handy, N. Ueno, E. Andreopoulou, R. Alvarez, V. Valero, S. Placido, G. Hortobagyi, J. Reuben, M. Cristofanilli (2012)
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.Annals of oncology : official journal of the European Society for Medical Oncology, 23 5
H. Schneck, C. Blassl, F. Meier-Stiegen, R. Neves, W. Janni, T. Fehm, H. Neubauer (2013)
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patientsMolecular Oncology, 7
S. Riethdorf, V. Müller, Liling Zhang, T. Rau, S. Loibl, M. Komor, M. Roller, J. Huober, T. Fehm, I. Schrader, J. Hilfrich, F. Holms, H. Tesch, H. Eidtmann, M. Untch, G. Minckwitz, K. Pantel (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro TrialClinical Cancer Research, 16
S. Nagrath, L. Sequist, S. Maheswaran, D. Bell, D. Irimia, L. Ulkus, Matthew Smith, E. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. Balis, R. Tompkins, D. Haber, M. Toner (2007)
Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 450
Daniel Hayes, D. Hayes, R. Bast, C. Desch, H. Fritsche, N. Kemeny, J. Jessup, G. Locker, J. Macdonald, R. Mennel, Larry Norton, P. Ravdin, S. Taube, R. Winn (1996)
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.Journal of the National Cancer Institute, 88 20
Circulating tumor cells (CTCs) represent tumor cells in the blood stream dislodged from the primary tumor. The presence of CTCs in the bloodstream provides a unique opportunity to sample cancer tissue by means of a relatively less-invasive “liquid biopsy.” Over the past decade, there has been a tremendous increase in the amount of research examining the potential clinical utility of CTCs in the management of cancer. A number of techniques to refine the sensitivity and range of CTC assays are also in development. In this article, we review the recent developments in the current and potential clinical applications of CTCs in breast cancer. CTC enumeration already has an established role as a prognostic biomarker in metastatic breast cancer, whereas molecular characterization of CTCs can serve as a potential predictive biomarker for therapy selection, pharmacodynamic evaluation, and identification of novel actionable targets for novel therapies. The role of CTCs in breast cancer screening and detection of recurrence is currently limited. Further development in techniques will be pivotal in enhancing the broad applicability of CTCs and advancing the field of personalized breast cancer therapy.
Current Breast Cancer Reports – Springer Journals
Published: May 10, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.